TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCA

$467,477UL1FY2009RRNIH

Tufts University Boston, Boston MA

Investigators

Linked publications, trials & patents

Paper 39078712 Paper 39037801 Paper 38554284 Paper 38497469 Paper 38362733 Paper 38108158 Paper 37992982 Paper 37721317 Paper 37717845 Paper 37378472 Paper 37204788 Paper 36865252 Paper 36857053 Paper 36519451 Paper 36223105 Paper 35973732 Paper 35945470 Paper 35919535 Paper 35675790 Paper 35383680 Paper 35243872 Paper 35089354 Paper 35006243 Paper 35005320 Paper 34826341 Paper 34823375 Paper 34786815 Paper 34706146 Paper 34473302 Paper 34470584 Paper 34452880 Paper 34437765 Paper 34419131 Paper 34401721 Paper 34010531 Paper 33888247 Paper 33861306 Paper 33827080 Paper 33647393 Paper 33583199 Paper 33517683 Paper 33429036 Paper 33404789 Paper 33388349 Paper 33333147 Paper 33305291 Paper 33301877 Paper 33161773 Paper 33100049 Paper 33098800 Paper 33044494 Paper 32906135 Paper 32829666 Paper 32807060 Paper 32634120 Paper 32591439 Paper 32559272 Paper 32376678 Paper 32362229 Paper 32163578 Paper 32111704 Paper 31983312 Paper 31874800 Paper 31865790 Paper 31862174 Paper 31840813 Paper 31778222 Paper 31777188 Paper 31647127 Paper 31465130 Paper 31343582 Paper 31338481 Paper 31324734 Paper 31262489 Paper 31257404 Paper 31256717 Paper 31022000 Paper 30977767 Paper 30939472 Paper 30655182 Paper 30644003 Paper 30517599 Paper 30461547 Paper 30425104 Paper 30357395 Paper 30352748 Paper 30276562 Paper 30256784 Paper 29944573 Paper 29897639 Paper 29854969 Paper 29721768 Paper 29712745 Paper 29685860 Paper 29671345 Paper 29596218 Paper 29577107 Paper 29567858 Paper 29564978 Patent 8841109

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This supplemental award provides funds to CTSA Consortium-supported research projects for research on outcome measures in clinical and translational child health in priority areas as determined by the Best Pharmaceuticals for Children Act (BPCA) program administered by NICHD.

View original record on NIH RePORTER →